Vol 26, No 1 (2025)

Table of Contents

Review (Economic Analysis)

[Horizon Scanning Of Therapeutic Alternatives For Generalized Myasthenia Gravis And Five-Year Healthcare Expenditure Forecast Model]
Silvia Adami, Paolo Emilio Alboni, Adriano Cristinziano, Concetta La Seta, Andrea Marinozzi, Emanuele Colalillo, Rossella Bitonti
HTML PDF

Original research

Cost Evaluation and Economic Sustainability of Enzyme Replacement Therapies for Fabry Disease in Italy from the Hospital Perspective
Gianni Ghetti, Eleonora Spiombi, Lucrezia Amoroso, Raffaella Viti, Marco Spada
HTML PDF
[Cost-Effectiveness Analysis of TTFields with TMZ Versus TMZ in Monotherapy in Patients with Grade 4 Glioma in Italy]
Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi, Antonio Silvani, Pietro Ferrara, Giorgia Gribaudo, Lorenzo Losa, Lorenzo Giovanni Mantovani
HTML PDF
[Cost Evaluation of First-Year Treatment for Locally Advanced or Metastatic Urothelial Carcinoma with Chemotherapy Plus Avelumab vs Chemotherapy Plus Best Supportive Care: A Cost of Care Model]
Daniela Paola Roggeri, Alessandro Roggeri, Anna Maria Provenzano, Francesca Ludovica Boffo, Roberto Iacovelli
HTML PDF
[Complementary Strategy of RSVpreF Vaccination/Nirsevimab versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]
Giorgio Lorenzo Colombo, Giuseppe Novelli
HTML PDF
A Real-World Analysis of Patients with Triple Class Exposed Multiple Myeloma in Italy: Epidemiology Estimates, Treatment Pattern and Economic Burden
Valentina Perrone, Stefania Mazzoni, Maria Cappuccilli, Roberto Di Virgilio, Luca Degli Esposti
HTML PDF
Tinzaparin for the Management of Cancer Associated Thrombosis in Patients with Cancer: a Budget Impact Analysis from the Italian Healthcare System Perspective
Lorenzo Giovanni Mantovani, Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi
HTML PDF
[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]
Paolo Gisondi, Andrea Chiricozzi, Marcello Pani, Massimiliano Povero, Luca Castello, Maria Paola Pedone, Kerry Noonan, Zhixiao Wang, Roberta Di Turi
HTML PDF
Retifanlimab Vs Avelumab in Patients with Metastatic Merkel Cell Carcinoma: A Cost Utility Analysis in Italy
Gianni Ghetti, Camilla Porta, Massimiliano Povero
HTML PDF
Real-World Outcomes of Single-Inhaler Triple Therapy Prescribed by General Practitioners in Managing Chronic Obstructive Pulmonary Disease: A Systematic Literature Review
Linet Odonde, Lorenzo Pradelli, Claudio Micheletto
HTML PDF
Therapeutic Journey and Economic Burden of Patients with Myasthenia Gravis in Italy: Results of a Real-World Analysis
Valentina Perrone, Stefania Mazzoni, Maria Cappuccilli, Margherita Andretta, Marcello Bacca, Antonietta Barbieri, Fausto Bartolini, Alessandro Chinellato, Andrea Ciaccia, Alberto Costantini, Francesco De Vita, Stefania Dell'Orco, Fulvio Ferrante, Simona Gentile, Stefano Grego, Daniela Mancini, Marzia Mensurati, Rossella Moscogiuri, Romina Pagliaro, Nicola Petragnani, Cataldo Procacci, Davide Re, Fiorenzo Santoleri, Michele Giuseppe Tari, Loredana Ubertazzo, Carlo Giuseppe Antozzi, Luca Degli Esposti
HTML PDF
Designing a Model for the Management of Modern Health Services of Middle-aged Adults in the Iranian Health System
Fatemeh Dabaghi, Ghahraman Mahmoodi, Azadeh Ahmadi Dashtian, Akbar Shokri
HTML PDF